PD.1.03 Ensartinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients: Updated Data

Authors :: Leora Horn
K. Harrow
Heather A. Wakelee
Chris Liang
George R. Blumenschein
Sandip Pravin Patel
Joel W. Neal
A. Holzhausen
Karen L. Reckamp
Ticiana A. Leal
S. Waqar
Gary Dukart
Source :: Journal of Thoracic Oncology. 13:S156
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
business.industry
ALK-Positive
Cancer research
medicine
non-small cell lung cancer (NSCLC)
Anaplastic lymphoma kinase
medicine.disease
business

Tools